This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khor, T. O. Articles by Kong, A.-N. Search for Related Content PubMed PubMed Citation Articles by Khor, T. O. Articles by Kong, A.-N.

Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis

¹ Department of Pharmaceutics, ² Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey; and ³ Department of Pathology, University of California, Medical Sciences, Irvine, California

Requests for reprints: Ah-Ng Kong, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854. Phone: 732-445-3831, ext. 228; Fax: 732-445-3134; E-mail: KongT{at}rci.rutgers.edu.

Inflammatory bowel diseases, chronic inflammatory disorders, have been strongly linked with an increased risk of the development of colorectal cancer. Understanding the etiology of these diseases is pivotal for the improvement of currently available strategies to fight against inflammatory bowel disease, and more importantly, to prevent colorectal cancer. Nuclear factor-erythroid 2–related factor 2 (Nrf2) has been known to be a transcriptional factor which plays a crucial role in cytoprotection against inflammation, as well as oxidative and electrophilic stresses. The aim of this study is to investigate the role of Nrf2 in the regulation of dextran sulfate sodium (DSS)–induced experimental colitis in mice. Nrf2-deficient mice were found to be more susceptible to DSS-induced colitis as shown by the increased severity of colitis following 1 week of oral administration of 1% DSS. The increased severity of colitis in Nrf2(–/–) mice was found to be associated with decreased expression of antioxidant/phase II detoxifying enzymes including heme-oxygenase-1, NAD(P)H-quinone reductase-1, UDP-glucurosyltransferase 1A1, and glutathione S-transferase Mu-1. In addition, proinflammatory mediators/cytokines such as COX-2, inducible nitric oxide, interleukin 1ß, interleukin 6, and tumor necrosis factor were significantly increased in the colonic tissues of Nrf2(–/–) mice compared with their wild-type (Nrf2+/+) counterparts. In summary, we show for the first time that mice lacking Nrf2 are more susceptible to DSS-induced colitis. Our data suggests that Nrf2 could play an important role in protecting intestinal integrity, through regulation of proinflammatory cytokines and induction of phase II detoxifying enzymes. (Cancer Res 2006; 66(24): 11580-4)

This article has been cited by other articles:

				N. Eynon, M. Sagiv, Y. Meckel, J. A. Duarte, A. J. Alves, C. Yamin, M. Sagiv, E. Goldhammer, and J. Oliveira NRF2 intron 3 A/G polymorphism is associated with endurance athletes' status J Appl Physiol, July 1, 2009; 107(1): 76 - 79. [Abstract] [Full Text] [PDF]

				W. Jin, H. Wang, Y. Ji, L. Zhu, W. Yan, L. Qiao, and H. Yin Genetic Ablation of Nrf2 Enhances Susceptibility to Acute Lung Injury After Traumatic Brain Injury in Mice Experimental Biology and Medicine, February 1, 2009; 234(2): 181 - 189. [Abstract] [Full Text] [PDF]

				H.-Y. Cho, F. Imani, L. Miller-DeGraff, D. Walters, G. A. Melendi, M. Yamamoto, F. P. Polack, and S. R. Kleeberger Antiviral Activity of Nrf2 in a Murine Model of Respiratory Syncytial Virus Disease Am. J. Respir. Crit. Care Med., January 15, 2009; 179(2): 138 - 150. [Abstract] [Full Text] [PDF]

				T. O. Khor, M.-T. Huang, A. Prawan, Y. Liu, X. Hao, S. Yu, W. K. L. Cheung, J. Y. Chan, B. S. Reddy, C. S. Yang, et al. Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal Cancer Cancer Prevention Research, August 1, 2008; 1(3): 187 - 191. [Abstract] [Full Text] [PDF]

				W. O. Osburn, M. S. Yates, P. D. Dolan, S. Chen, K. T. Liby, M. B. Sporn, K. Taguchi, M. Yamamoto, and T. W. Kensler Genetic or Pharmacologic Amplification of Nrf2 Signaling Inhibits Acute Inflammatory Liver Injury in Mice Toxicol. Sci., July 1, 2008; 104(1): 218 - 227. [Abstract] [Full Text] [PDF]

				Y. Tanaka, L. M. Aleksunes, R. L. Yeager, M. A. Gyamfi, N. Esterly, G. L. Guo, and C. D. Klaassen NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 655 - 664. [Abstract] [Full Text] [PDF]

				N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF]

				W. Jin, L. Zhu, Q. Guan, G. Chen, Q. F. Wang, H. X. Yin, C. H. Hang, J. X. Shi, and H. D. Wang Influence of Nrf2 Genotype on Pulmonary NF-{kappa}B Activity and Inflammatory Response after Traumatic Brain Injury Ann. Clin. Lab. Sci., January 1, 2008; 38(3): 221 - 227. [Abstract] [Full Text] [PDF]